Investigators Probe FDA accelerated pathway Over Aduhelm

Investigators Probe FDA’s “Accelerated Pathway” Over Aduhelm

Following the controversial accelerated approval granted by the U.S. Food & drug Administration for Biogen’s Alzheimer’s treatment Aduhelm, an independent federal…